Boehringer Ingelheim and Funxional Therapeutics announce acquisition of Funxional’s FX125L and the somatotaxin portfolio to treat inflammation
23 July 2012 | By Boehringer Ingelheim
FX125L is a small molecule...
List view / Grid view
23 July 2012 | By Boehringer Ingelheim
FX125L is a small molecule...
26 May 2010 | By College Hill Life Sciences
Funxional Therapeutics, announced the...